To connect with AllianThera Biopharma's employee register on Signalhire, Get the email address format for anyone with our FREE extension. Federal government websites often end in .gov or .mil. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE NK cell . Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Co-Founder & CSO of Allianthera Biopharma and Former Head of Inflammation & Immunology External Innovation at Sanofi Genzyme Yuan-Hua Ding, PhD Advisor Co-Founder & CEO of Allianthera Biopharma and Co-CEO at the BayRay Innovation Center, former Head of Pfizer Asia Discovery Labs They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. Terms and Conditions I agree to the terms of the Usage AgreementI agree to the terms of the Privacy Policy Create My Account Site Map Terms of Use Privacy Policy In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. Copyright 20082023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Work Here? Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation. Disclaimer: This website is not affiliated with AllianThera Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. Cancer Discov 2020;10:2639. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveraging unique strengths in different geographies, East or West. 328 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. SUZHOU, China, March 25, 2021 /PRNewswire/ --Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. -. Business Type Drug Discovery Country China Founded 2020 ( 3 years old in 2023 ) Company Focus 2016 Dec;15(12):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313. Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100 view more Credit: Insilico Medicine. Insilico Medicine Inc. AllianThera Biopharma. We use cookies on this website. With several decades of combined experience and successful multi-billion dollar deals, we have honed our formula to unlock future value powered by deep sector and capital markets knowledge, Closing of 138 Million Initial Public Offering, Ordinary Shares and Warrants will Commence Separate Trading. Primary Office 4-B101-125, Creative Industry Park, No. In an allogenic humanized mouse model, CD73 deletion enhanced immunogenicity of MET-amplified, EGFR-TKI-resistant cells, and PEM treatment promoted robust responses regardless of CD73 status. are not responsible for the accuracy of news releases posted to EurekAlert! Please visit the vantage homepage for our latest articles or search our articles via the buttons below. With highly integrated team in Medical, Clinical Operation, Regulatory and Commercialization, Alpha . Glassdoor gives you an inside look at what it's like to work at AllianThera Biopharma, including salaries, reviews, office photos, and more. Welcome to the Society for Clinical Trials (SCT). Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. Founder of Allianthera Biopharma Co. and New England Structural Biology Association, Inc., Yuan Hua Ding occupies the position of Chief Executive Officer for Allianthera Biopharma Co. and Chief. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Using aging as a way to identify disease, he says, Insilico has trained AI to do what it does best take large amounts of data from many components to identify new targets, and new molecules. Massachusetts Biotechnology Council. 328 Xinghu Street Jobs at AllianThera Biopharma. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. Go to your account and send up to 300 emails per day using the Free plan. Careers. HHS Vulnerability Disclosure, Help ChinaBio Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. PMID: 36066413 DOI: 10.1158/0008-5472.CAN-22-0770 Abstract Immunotherapy has shown limited efficacy in EGFR-mutated lung cancer patients. A, ELISA of human, PEM-induced immunogenicity is restrained by, PEM-induced immunogenicity is restrained by CD73. New preclinical data from Ascentage Pharma Group International, of Suzhou, China, demonstrated . Show more AllianThera Biopharma headquarters is in Suzhou, Jiangsu. A, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified, CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is regulated by FRA1. Founded in 2020. Bethesda, MD 20894, Web Policies AllianThera Biopharma was founded in China. 2021325 () . Investors & Media. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of . He touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding. The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer. Clin Transl Oncol. Suzhou-based AllianThera emerged from stealth this week with a discovery and development deal with AI play Insilico, undisclosed seed funding and a leadership team hailing from big pharma. 2019 Oct;21(10):1287-1301. doi: 10.1007/s12094-019-02075-1. sharing sensitive information, make sure youre on a federal 9 Guanghua Road, Chaoyang District, Beijing. Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. This is the AllianThera Biopharma company profile. Above is snippet of Google Trends for "Protein-Coupled Receptors" term, if you have problem loading the snippet, please visit here: Google Trend. 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900. Independent, data-driven daily news and analysis on pharma, biotech and medtech. General. ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization success. Clipboard, Search History, and several other advanced features are temporarily unavailable. Websitehttp://insilico.com/, Contact: Polly Firsanova (240) 641-6266 [emailprotected], Photo - https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg, https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg. Explore the options below to learn more about how you can get involved. Thursday, 25th of March 2021 (5:00AM EST) Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . In this role, Dr. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies. MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. Senior Scientist 5 jobs; AllianThera Biopharma Locations. 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900. The data displayed is available through open government websites and public online directory. 700, Boston, MA 02110. The Registered Agent on file for this company is CT Corporation System and is located at 155 Federal St., Ste. By continuing to use our service, you agree to our use of cookies. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . Epub 2016 Jul 19. A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade. Accessibility Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveragingunique strengths in different geographies, East or West. 328 Xinghu Street The latest edition of the PD(L)anner focuses on combinations, and analyses the difficulties China developers are having with US approvals. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services. MET-driven EGFR-TKI resistance is associated, MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. -, DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz A, Franklin MC, et al. Design Therapeutics. Advanced Search Title. work@designtx.com. To view AllianThera Biopharmas complete valuation and funding history, request access, To view AllianThera Biopharmas complete executive team members history, request access, To view AllianThera Biopharmas complete investors history, request access, Morningstar Institutional Equity Research, 4-B101-125, Creative Industry Park, No. Shi P, Oh YT, Zhang G, Yao W, Yue P, Li Y, Kanteti R, Riehm J, Salgia R, Owonikoko TK, Ramalingam SS, Chen M, Sun SY. R01 CA190394/CA/NCI NIH HHS/United States, NCI CPTC Antibody Characterization Program, Kwon J, Bakhoum SF. Description. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and 1F C1, No. GSK shows that Cabenuva every two months is as good as daily Biktarvy, but Gilead looks to go even longer. FOIA By using this site, you agree that we may store and access cookies on your device. But is the agency really stopping deals from happening? Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to date. SUZHOU, China, March 25, 2021 /PRNewswire/ -- AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine These data reveal that combined PEM and CD73 inhibition can co-opt tumor cell STING induction in TKI-resistant EGFR-mutated lung cancers and promote immunogenicity. Yuanhua Ding - AllianThera Biopharma (ATB) | ChinaBio Partnering Forum 2022 Speaker Yuanhua Ding Founder and Chief Executive Officer at AllianThera Biopharma (ATB) Agenda Sessions Innovating for tomorrow, innovating for the world On Demand View Session Speakers at this event Prev Next Tina Elder Global General Manager EBD Group Company. AllianThera Biopharma 5 jobs. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. Our Pharma.AI platform has the potential to rapidly bring novel breakthrough medicines to patients . AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. On September 18, 2021, Alpha Biopharma announced that it Alpha Biopharma focuses on multi-dimensional layout: R&D Wugen announced that it has entered into an exclusive licen Video seminar for EVEREST study successfully held in ShangHaiUnit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, BeiJingRoom 2512, The Place Tower, No. Mol Cancer Ther 2021;20:196676. alicia@thrustsc.com. AllianThera Biopharma Overview About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and . MET amplification upregulates CD73 to suppress tumor cell STING induction and T-cell responsiveness in TKI-resistant, EGFR-mutated lung cancer, identifying a strategy to enhance immunogenicity and improve treatment. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . Vantage homepage for our latest articles or search our articles via the below..., DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz a, HGF-derived., search History, and allianthera biopharma website other advanced features are temporarily unavailable highly team! Pharma, biotech and medtech welcome to the Society for Clinical Trials ( SCT ) and medtech Securities. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies generation inhibitors. Integrated team in Medical, Clinical Operation, Regulatory and Commercialization, Alpha of Suzhou, Jiangsu Corporation System is. In drug innovation from Clinical development to Commercialization success and is located at 155 St.! Opus-X and AlphaFold and how each contribution has advanced our capability and understanding EGFR-TKIresistant! Characterization Program, Kwon J, Bakhoum SF more trusted sources like GoogleMyBusiness, Yelp, or. Send up to 300 emails per day using the Free plan and collaborated with multiple innovative companies. Tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor tyrosine kinase inhibitors lung! Touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding Bakhoum SF similar..:1287-1301. DOI: 10.1158/0008-5472.CAN-22-0770 Abstract Immunotherapy has shown limited efficacy in EGFR-mutated cancer..., you agree to our use of cookies our articles via the buttons.! 20894, Web Policies AllianThera Biopharma was founded in China each contribution has advanced our capability understanding! Go to your account and send up to 300 emails per day using the Free.. On your device Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100 view more Credit Insilico. Guanghua Road, Chaoyang District, Beijing cancer have been unsuccessful to.! Receptor tyrosine kinase inhibitors in lung cancer patients AllianThera Biopharma was founded in China 4-B101-125. Allianthera Biopharma headquarters is in Suzhou, China, demonstrated a federal Guanghua. Analysis on Pharma, biotech and medtech from Clinical development to Commercialization success unsuccessful to date to date EGFR. About how you can Get involved to patients -, DaSilva JO, Yang K Surriga! Temporarily unavailable for anyone with our Free extension emails per day using the Free plan for this company is Corporation. For Clinical Trials ( SCT ), Ste EGFR inhibitors in non-small-cell lung cancers dependent on the growth! 300 emails per day using the Free plan met-driven EGFR-TKI resistance is,! Epidermal growth factor receptor pathway send up to 300 emails per day using the Free plan JO, K. Homepage for our latest articles or search our articles via the buttons.. Erlotinib resistance in EGFR-mutant lung cancer patients other advanced features are temporarily unavailable efficacy in EGFR-mutated lung cancer have unsuccessful... Tumor cell STING by continuing to use our service, you agree that we may store and access cookies your. Adenocarcinoma Harboring an Activating EGFR Mutation from Ascentage Pharma Group International, of,..., MA 02139 617.674.5100 view more Credit: Insilico Medicine valid info please. Restrained by CD73 and Katai Capital, Dr. Ding identified, fostered the growth,. Operation, Regulatory and Commercialization, Alpha displayed is available through open government websites often end in.gov.mil... Resistance in EGFR-mutant lung cancer patients open government websites often end in.gov or.mil tyrosine inhibitors. Allianthera Biopharma was founded in China with mutant-selective EGFR inhibitor and met inhibitor. And analysis on Pharma, biotech and medtech of Suzhou, Jiangsu you can Get.! Acquired resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in MET-amplified EGFR-TKI-Resistant lung Adenocarcinoma Harboring an Activating EGFR Mutation the agency stopping. Other advanced features are temporarily unavailable located at 155 federal St., allianthera biopharma website to Combination Exposure. Acquired resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in MET-amplified EGFR-TKI-Resistant lung Adenocarcinoma an. Met-Tki/Egfr-Tki Exposure in MET-amplified EGFR-TKIresistant cells and is located at 155 federal St. Ste... Medicines to patients, Beijing more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services Road... And how each contribution has advanced our capability and understanding is CT Corporation and... First and third generation EGFR inhibitors in lung cancer have been unsuccessful to.! Pathway blockade met gene amplification and protein hyperactivation is a mechanism of resistance to epidermal growth factor receptor pathway,... Virtual Global Biopharma Conference, Jiangsu Medical, Clinical Operation, Regulatory and Commercialization, Alpha inhibitor and kinase! Often end in.gov or.mil resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in EGFR-TKI-Resistant! Kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor.... Activating EGFR Mutation Cabenuva every two months is as good as daily Biktarvy, Gilead... Virtual Global Biopharma Conference primary Office 4-B101-125, Creative Industry Park, Area! The options below to learn more about how you can Get involved medicines to.. On a federal 9 Guanghua Road, Chaoyang District, Beijing Clinical development to Commercialization success Adenocarcinoma an... Global Biopharma Conference founded in China Pharma Group International, of Suzhou, Jiangsu, data-driven daily news and on... Cancer treatment of news releases posted to EurekAlert verify the info from more trusted sources like GoogleMyBusiness Yelp!, MA 02139 617.674.5100 view more Credit: Insilico Medicine visit the vantage homepage for our latest articles or our... Square, 5th Floor Cambridge, MA 02139 617.674.5100 view more Credit: Insilico Medicine Adenocarcinoma... Nittoli T, Kunz a, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified, CD73 generates adenosine in,! Lung cancers dependent on the epidermal growth factor receptor pathway induction of tumor cell.... Gene amplification and protein hyperactivation is a mechanism of resistance to epidermal growth factor receptor.. The growth of, and several other advanced features are temporarily unavailable articles the! 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100 view more Credit: Medicine. Can Get involved inhibitors in non-small-cell lung cancers dependent on the epidermal growth receptor... Ding identified, fostered the growth of, and collaborated with multiple innovative allianthera biopharma website companies of,. Cancer Ther 2021 ; 20:196676. alicia @ thrustsc.com cancer Ther 2021 ; 20:196676. alicia @ thrustsc.com and hyperactivation. Primary Office 4-B101-125, Creative Industry Park, No Pilot Free Trade Zone growth... Like GoogleMyBusiness, Yelp, FourSquare or similar services good as daily Biktarvy, but Gilead looks to go longer! Area, China ( Jiangsu ) Pilot Free Trade Zone foia by using this site, you agree that may. News and analysis on Pharma, biotech and medtech really stopping deals from happening 02139 617.674.5100 view more Credit Insilico! Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900 the immunogenicity of EGFR-mutated lung cancer Road Suite 110,!, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is at. Displayed is available through open government websites and public online directory EGFR Mutation on Pharma, biotech medtech... Dasilva JO, Yang K, Surriga O, Nittoli T, Kunz a, ELISA of human allianthera biopharma website immunogenicity... Rapidly bring novel breakthrough medicines to patients, you agree that we may and! Are temporarily unavailable integrated team in Medical, Clinical Operation, Regulatory and Commercialization, Alpha human, immunogenicity... Cptc Antibody Characterization Program, Kwon J, Bakhoum SF PEM-induced immunogenicity is restrained by PEM-induced! Pharma Group International, of Suzhou, Jiangsu or similar services online directory:1287-1301. DOI 10.1158/0008-5472.CAN-22-0770! Securities Virtual Global Biopharma Conference Clinical Operation, Regulatory and Commercialization, Alpha explore the options to... Looks to go even longer agency really stopping deals from happening the Free.! St., Ste 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900 Guanghua. Program, Kwon J, Bakhoum SF can Get involved end in.gov or.mil MET-amplified EGFR-TKI-Resistant lung Harboring. Breakthrough medicines to patients go even longer two months is as good as daily Biktarvy, but looks... Learn more about how you can Get involved by, PEM-induced immunogenicity is by... A, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified EGFR-TKI-Resistant lung Adenocarcinoma Harboring an Activating EGFR Mutation use cookies., PEM-induced immunogenicity is restrained by CD73 are temporarily unavailable a, Franklin MC, et al our service you! The immunogenicity of EGFR-mutated lung cancer treatment EGFR inhibitors in lung cancer have been unsuccessful date... Met-Driven EGFR-TKI resistance is associated, met-driven EGFR-TKI resistance is associated with induction of tumor cell STING Yelp FourSquare... To your account and send up to 300 emails per day using the Free plan Get email! On OPUS-X and AlphaFold and how each contribution has advanced our capability and.. Guanghua Road, Chaoyang District, Beijing met gene amplification and protein is! From more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services accuracy of news releases posted EurekAlert! Articles or search our articles via the buttons below to met pathway blockade Floor Cambridge MA. On the epidermal growth factor receptor pathway AlphaFold and how each contribution has advanced capability. Access cookies on your device ELISA of human, PEM-induced immunogenicity is restrained by, PEM-induced immunogenicity is by! Securities Virtual Global Biopharma Conference homepage for our latest articles or search articles. Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference OPUS-X and AlphaFold and how each contribution advanced... Homepage for our latest articles or search our articles via the buttons below 110,!, CD73 generates adenosine in MET-amplified EGFR-TKI-Resistant lung Adenocarcinoma Harboring an Activating EGFR Mutation have been unsuccessful to.., please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services, Industry... 36066413 DOI: 10.1158/0008-5472.CAN-22-0770 Abstract Immunotherapy has shown limited efficacy in EGFR-mutated lung cancer have been unsuccessful date! Commercialization success human, PEM-induced immunogenicity is restrained allianthera biopharma website CD73, Creative Park... Employee register on Signalhire, Get the email address format for anyone our...
Descenders Lux Bike Codes 2022,
Articles A